Aram F. Hezel, M.D.

Cancer

Clinical Interests

Gastrointestinal, Foregut, Stomach, Liver Cancer; Medical Oncology

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Administrative: (585) 275-9484

Office: (585) 275-5823

Fax: (585) 273-1042

A member of the University of Rochester Medical Faculty Group

An Accountable Health Partner

Accepting New Patients

Locations

Wilmot Cancer Institute
601 Elmwood Ave
Rochester, NY 14642-0001

Oncology: (585) 275-5823

Faculty Appointments

Associate Professor - Department of Medicine , Hematology/Oncology (SMD)
John and Ethel Heselden Professorship - Department of Medicine , Hematology/Oncology (SMD)
Chief - Department of Medicine , Hematology/Oncology (SMD)
Associate Professor - Cancer Center - Joint
Associate Professor - Department of Biomedical Genetics (SMD) - Joint

Biography

I chose this field because as a young man, I was profoundly impacted by the death of my grandfather from cancer, and then later in medical school, I was drawn at a scientific and personal level to the care of people facing cancer.
?Every patient is different – and so is each cancer. Doing the best I can to understand patients and their families, what is important to them and providing the best possible care is my goal. While many people face cancer, each person does so with specific concerns, fears and beliefs. I will always do my best to provide the highest quality care, while preserving a patient's dignity.

My areas of special interest include clinical trials with new therapies for gastrointestinal cancers, and understanding the genetics and biology of pancreatic and liver cancers.

Conditions I Treat

- Esophageal cancer
- Stomach cancer
- Liver cancer
- Pancreatic cancer
- Bowel cancer
- Colon cancer
- Rectal cancer
- Anal cancer
- Gastrointestinal stromal tumors (GIST)
- Neuroendocrine tumors
- Carcinoid tumors

Credentials

Specialties

Internal Medicine
Medical Oncology

Education

1995
BA | Vassar College
Not Specifically Classified

2000
MD | Univ at Buffalo SUNY School of Medicine & Biomedical Sciences
Medicine

Post-doctoral Training & Residency

07/01/2003 - 06/30/2006
Fellowship in Medical Oncology at Dana Farber Cancer Institute/ Partners

07/01/2001 - 06/30/2003
Residency in Internal Medicine at Beth Israel Deaconess Medical Center

07/01/2000 - 06/30/2001
Internship in at Beth Israel Deaconess Medical Center

VIEW ALL

Awards

2013
Patient & Family Centered Care Top Performer Award
Location: University of Rochester, American Cancer Society

2013
American Cancer Society Career Development Award

2012
Teacher of the Year Award
Location: University of Rochester, Division of Hematology & Oncology

2011
Teacher of the Year Award
Location: University of Rochester, Division of Hematology & Oncology

2010
Edelman Gardner Research Award
Location: University of Rochester, Wilmot Cancer Center

2007
Howard Hughes Medical Institute Physician-Scientist Early Career Award

2006
NCI Career Development Award: K08 CA122835-03

2005
PanCAN/ASCO Young Investigator Award

2000
Loretta A. Jordan Award for Research of Neoplastic Disease

2000
Robin Bannerman Memorial Research Award

1999
Howard Hughes Medical Institute Research Training Fellowship for Medical Students

1998
Howard Hughes Medical Institute Research Training Fellowship

1997
John Harford/American Federation for Aging Research
Location: Medical School Research Fellowship

1996 - 1997
Dean's List for Academic Excellence
Location: SUNY Buffalo School of Medicine

VIEW ALL

Publications

Journal Articles

2014
Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N. "Mutant IDH inhibits HNF-4? to block hepatocyte differentiation and promote biliary cancer." Nature. 2014; 10.1038/nature13441.

2014
Hezel AF, Noel MS, Allen JN, Abrams TA, Yurgelun M, Faris JE, Goyal L, Clark JW, Blaszkowsky LS, Murphy JE, Zheng H, Khorana AA, Connolly GC, Hyrien O, Baran A, Herr M, Ng K, Sheehan S, Harris DJ, Regan E, Borger DR, Iafrate AJ, Fuchs C, Ryan DP, Zhu AX. "Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer. ." Br J Cancer.;111(3):430-6. doi: 10.1038/bjc.2014.343. Epub 2014 Jun 24. 2014; .

2013
Connolly GC, Safadjou S, Kashyap R, Chen R, Orloff MS, Hezel AF. "Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma." BMC Gastroenterology. 2013; : 139.

VIEW ALL PUBLICATIONS